Literature DB >> 12918095

Progress in searching for susceptibility gene for inflammatory bowel disease by positional cloning.

Chang-Qing Zheng1, Gang-Zheng Hu, Zhao-Shu Zeng, Lian-Jie Lin, Gin-Ge Gu.   

Abstract

Inflammatory bowel disease (IBD) includes two clinical subtypes: Crohn disease (CD) and ulcerative colitis (UC). The general prevalence is about 1.0-2.0 % in Western countries. It is predominantly regarded as a multifactorial disorder involving environmental factors and polygenic defects. The view was confirmed by a lot of evidences from clinical attributions and animal models, especially from epidemiological investigations. So the etiological study of IBD has been focused on searching for susceptibility genes by positional cloning, which consists of two steps: linkage analysis and association analysis. Linkage analysis has been an important method of searching for susceptibility genes to polygenic diseases as well as single-gene disorders. IBD, as a polygenic disease, has been widely investigated by linkage analysis for susceptibility gene since 1996. The paper reviewed 38 articles, which covered almost all original researches in relation to IBD and linkage analysis. So far, several loci, such as 16q, 12q, 6p and 3p, have been identified by the studies. The most striking is 16q12 (IBD1), which linked only with CD not UC in the majority of studies. Association analysis, as one essential step for positional cloning, is usually carried out by genotyping candidate genes selected by means of linkage analysis or other methods, for figuring out the frequencies of alleles and comparing the frequencies between IBD group and healthy control group to identify the specific allele. It has been established that IBD is implicated in immune disorder. So the studies were centered on the genes of NOD2/CARD15, HLA-II, cytokine, cytokine receptor and adhesion molecule. This paper reviewed 14 original articles on association between NOD2 and IBD that have been published since 2001. All results, with the exception of one report from a Japanese group, provide evidences that the three kinds of variants of NOD2 are susceptibility factors for IBD. This article also comprehensively analyzed 18 original researches of HLA gene polymorphism in IBD. We found extensive discrepancy among the conclusions and a novel hypothesis was put forward to explain the discordance. Most studies published recently on association between IBD and cytokine gene polymorphism were reviewed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12918095      PMCID: PMC4611518          DOI: 10.3748/wjg.v9.i8.1646

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  125 in total

1.  Th1-type responses mediate spontaneous ileitis in a novel murine model of Crohn's disease.

Authors:  M M Kosiewicz; C C Nast; A Krishnan; J Rivera-Nieves; C A Moskaluk; S Matsumoto; K Kozaiwa; F Cominelli
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Linkage heterogeneity for the IBD1 locus in Crohn's disease pedigrees by disease onset and severity.

Authors:  S R Brant; C I Panhuysen; J E Bailey-Wilson; P M Rohal; S Lee; J Mann; G Ravenhill; B S Kirschner; S B Hanauer; J H Cho; T M Bayless
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

3.  Replication and extension studies of inflammatory bowel disease susceptibility regions confirm linkage to chromosome 6p (IBD3).

Authors:  B Dechairo; C Dimon; D van Heel; I Mackay; M Edwards; P Scambler; D Jewell; L Cardon; N Lench; A Carey
Journal:  Eur J Hum Genet       Date:  2001-08       Impact factor: 4.246

4.  Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.

Authors:  J Satsangi; K I Welsh; M Bunce; C Julier; J M Farrant; J I Bell; D P Jewell
Journal:  Lancet       Date:  1996-05-04       Impact factor: 79.321

5.  Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease, but not in ulcerative colitis.

Authors:  J D Ohmen; H Y Yang; K K Yamamoto; H Y Zhao; Y Ma; L G Bentley; Z Huang; S Gerwehr; S Pressman; C McElree; S Targan; J I Rotter; N Fischel-Ghodsian
Journal:  Hum Mol Genet       Date:  1996-10       Impact factor: 6.150

6.  Is interleukin-6 important in inflammatory bowel disease?

Authors:  K Koss; J Satsangi; K I Welsh; D P Jewell
Journal:  Genes Immun       Date:  2000-02       Impact factor: 2.676

7.  Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD): influence on disease behaviour?

Authors:  E Louis; M Peeters; D Franchimont; L Seidel; F Fontaine; G Demolin; F Croes; P Dupont; L Davin; S Omri; P Rutgeerts; J Belaiche
Journal:  Clin Exp Immunol       Date:  2000-01       Impact factor: 4.330

8.  CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease.

Authors:  Suzanne Lesage; Habib Zouali; Jean-Pierre Cézard; Jean-Frédéric Colombel; Jacques Belaiche; Sven Almer; Curt Tysk; Colm O'Morain; Miquel Gassull; Vibeke Binder; Yigael Finkel; Robert Modigliani; Corinne Gower-Rousseau; Jeanne Macry; Françoise Merlin; Mathias Chamaillard; Anne-Sophie Jannot; Gilles Thomas; Jean-Pierre Hugot
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

9.  Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease.

Authors:  H Yang; D K Vora; S R Targan; H Toyoda; A L Beaudet; J I Rotter
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

10.  Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup.

Authors:  R H Duerr; D A Neigut
Journal:  Gastroenterology       Date:  1995-02       Impact factor: 22.682

View more
  16 in total

1.  Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001.

Authors:  Laszlo Lakatos; Gabor Mester; Zsuzsanna Erdelyi; Mihaly Balogh; Istvan Szipocs; Gyorgy Kamaras; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2004-02-01       Impact factor: 5.742

2.  DLG5 variants do not influence susceptibility to inflammatory bowel disease in the Scottish population.

Authors:  C L Noble; E R Nimmo; H Drummond; L Smith; I D R Arnott; J Satsangi
Journal:  Gut       Date:  2005-04-20       Impact factor: 23.059

Review 3.  Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe?

Authors:  L Lakatos; P L Lakatos
Journal:  Postgrad Med J       Date:  2006-05       Impact factor: 2.401

4.  Loss of fragile histidine triad protein expression in inflammatory bowel disease.

Authors:  Chun-Mei Xu; Chuan-Hu Qiao
Journal:  World J Gastroenterol       Date:  2006-12-07       Impact factor: 5.742

5.  1007fs, G908R, R702W mutations and P268S, IVS8+158 polymorphisms of the CARD15 gene in Turkish inflammatory bowel disease patients and their relationship with disease-related surgery.

Authors:  Ali Tüzün Ince; Ozden Hatirnaz; Oya Ovünç; Uğur Ozbek
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

6.  Effects of surgery on peripheral N-terminal propeptide of type III procollagen in patients with Crohn's disease.

Authors:  Matilde De Simone; Michele M Ciulla; Ugo Cioffi; Luca Poggi; Barbara Oreggia; Roberta Paliotti; Fiorenzo Botti; Alberto Carrara; Fiorenza Agosti; Alessandro Sartorio; Ettore Contessini-Avesani
Journal:  J Gastrointest Surg       Date:  2007-08-09       Impact factor: 3.452

Review 7.  Familial aggregation in inflammatory bowel disease: is it genes or environment?

Authors:  Tiago Nunes; Gionata Fiorino; Silvio Danese; Miquel Sans
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

8.  RAGE gene three polymorphisms with Crohn's disease susceptibility in Chinese Han population.

Authors:  Zheng-Ting Wang; Jia-Jia Hu; Rong Fan; Jie Zhou; Jie Zhong
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

9.  Clinical effects of adalimumab treatment with concomitant azathioprine in Japanese Crohn's disease patients.

Authors:  Kumi Ishida; Takuya Inoue; Kaori Fujiwara; Taisuke Sakanaka; Ken Narabayashi; Sadaharu Nouda; Toshihiko Okada; Kazuki Kakimoto; Takanori Kuramoto; Ken Kawakami; Yosuke Abe; Toshihisa Takeuchi; Mitsuyuki Murano; Satoshi Tokioka; Eiji Umegaki; Kazuhide Higuchi
Journal:  World J Gastroenterol       Date:  2013-05-07       Impact factor: 5.742

Review 10.  Recent advances in basic and clinical aspects of inflammatory bowel disease: which steps in the mucosal inflammation should we block for the treatment of inflammatory bowel disease?

Authors:  Hitoshi Asakura; Kenji Suzuki; Terasu Honma
Journal:  World J Gastroenterol       Date:  2007-04-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.